Head and neck cancer

Showing 5 of 0 results

• Machine learning risk stratification in a US-based database to identify subgroups of patients with head and neck cancer who benefit from adding chemotherapy to pembrolizumab

  ASCO Annual Meeting

  • Publication summary
  • Publications
  • Machine learning
  • Comparative effectiveness
  • Head and neck cancer
  • Artificial intelligence
• Real-world time on treatment with immuno-oncology therapy in recurrent/metastatic head and neck squamous cell carcinoma

  Future Oncology

  • Publications
  • Treatment patterns
  • Head and neck cancer
• Real-world treatment patterns and time on treatment (rwToT) in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) with disease progression on or after platinum-containing chemotherapy in United States (U.S.)

  Multidisciplinary Head and Neck Cancers Symposium

  • Publications
  • Treatment patterns
  • Head and neck cancer
• Organ dysfunction and clinical outcomes in patients treated with immune checkpoint inhibitors

  ASCO Annual Meeting

  • Publications
  • Unmet need
  • Renal cell carcinoma
  • Melanoma
  • Gastric/Esophageal cancer
  • Non-small cell lung cancer
  • Head and neck cancer
• Development and initial validation of a prognostic score based on structured data from EHRs

  AACR Annual Meeting

  • Publications
  • Methodology
  • Renal cell carcinoma
  • Urothelial cell carcinoma
  • Melanoma
  • Non-small cell lung cancer
  • Head and neck cancer